Sign In
Buy DXCM
$82.66
-4.28 (-4.92%)
At Close: Aug 05, 2026
DexCom's (DXCM) Q2 Earnings Beat Estimates, Revenues Miss
01:21pm, Friday, 26'th Jul 2024
DexCom's (DXCM) second-quarter 2024 earnings surpass expectations while revenues fall short. The Sensor segment and CGM system expansion drive growth.
Levi & Korsinsky Announces an Investigation on Behalf of DexCom, Inc. (DXCM) Shareholders Who May Have Been Affected by Fraud
01:00pm, Friday, 26'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 26, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of DexCom, Inc. ("DexCom") (NASDAQ:DXCM) concerning possible violations of federa
NEW YORK, NY / ACCESSWIRE / July 26, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into DexCom, Inc. (NASDAQ:DXCM) for potential violations of the federal se
DexCom Faces Short-Term Challenges, But Market Growth Prospects Remain Strong: Analyst
11:59am, Friday, 26'th Jul 2024
DexCom Inc DXCM reported second-quarter sales of more than $1 billion. That's up 15% year-over-year on a reported basis and 16% on an organic basis.
Dexcom Stock Sinks on Sales Miss, Guidance Cut: What to Know
11:58am, Friday, 26'th Jul 2024
Dexcom stock is crashing Friday after the glucose monitoring company reported dismal Q2 revenue and slashed its full-year sales guidance. Here's what you need to know.
DexCom (DXCM) Guidance Plummets Stock After Earnings
11:07am, Friday, 26'th Jul 2024
A major sell-off in the company happened Friday after it missed the top and bottom line in its 2Q24 earnings report. George Tsilis talks about how Dexcom's guidance is to blame for the falling stock.
DexCom slashes full-year sales forecast, shares plummet
11:00am, Friday, 26'th Jul 2024
DexCom Inc (NASDAQ:DXCM, ETR:DC4), a medical device maker that produces continuous glucose monitoring systems for diabetes management, shares plunged by more than 40% after the company slashed its an
DexCom, Inc. (DXCM) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
10:45am, Friday, 26'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 26, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of DexCom, Inc. ("DexCom") (NASDAQ:DXCM) concerning possible violations of federa
Why DexCom Stock Is Crashing Today
10:42am, Friday, 26'th Jul 2024
DexCom reported mixed Q2 results with an earnings beat, but revenue missed expectations. The company lowered its full-year revenue guidance.
Dexcom (DXCM) Stock Is Plunging on an ‘Execution Miss.' What Is Really Going On?
10:15am, Friday, 26'th Jul 2024
Dexcom (NASDAQ: DXCM ) stock is down over 40% after reporting disappointing revenue for the second quarter. It also lowered guidance for the rest of the year.
NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into DexCom, Inc. (NASDAQ: DXCM) for potential violations of the federal s
DexCom Stock Plunges 37% After Earnings. GLP-1s Weren't the Problem.
08:49am, Friday, 26'th Jul 2024
Revenue guidance was.
Johnson Fistel Begins Investigation into DexCom Following a Significant Drop in the Company's Stock
08:33am, Friday, 26'th Jul 2024
SAN DIEGO, July 26, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether DexCom, Inc. (NASDAQ: DXCM) or any of its executive officers or others violated se
Why Is DexCom (DXCM) Stock Down 38% Today?
08:29am, Friday, 26'th Jul 2024
DexCom (NASDAQ: DXCM ) stock is falling on Friday after the company released its earnings report for Q2 2024. DexCom starts its earnings report with adjusted earnings per share of 43 cents.
DexCom, Zynex, Olin And Other Big Stocks Moving Lower In Friday's Pre-Market Session
08:05am, Friday, 26'th Jul 2024
U.S. stock futures were higher this morning, with the Dow futures gaining around 200 points on Friday.
